{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:19:13Z","timestamp":1785151153506,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.rmed.2026.108633","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:38:58Z","timestamp":1767339538000},"page":"108633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Clinical stability under FF\/UMEC\/VI triple inhaled therapy: A 12-month real life retrospective observational study"],"prefix":"10.1016","volume":"252","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-9921","authenticated-orcid":false,"given":"Mauro","family":"Maniscalco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5888-8781","authenticated-orcid":false,"given":"Claudio","family":"Candia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0081-8769","authenticated-orcid":false,"given":"Francesco","family":"Pennisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfio","family":"Pennisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Ambrosino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2026.108633_bib1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12916-025-04014-0","article-title":"Mapping the global distribution, risk factors, and temporal trends of COPD incidence and mortality (1990\u20132021): ecological analysis","volume":"23","author":"Naeem","year":"2025","journal-title":"BMC Med."},{"key":"10.1016\/j.rmed.2026.108633_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.76","article-title":"Chronic obstructive pulmonary disease","volume":"1","author":"Barnes","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.rmed.2026.108633_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1183\/23120541.00181-2021","article-title":"Changes in health-related quality of life as a marker in the prognosis in COPD patients","volume":"8","author":"Esteban","year":"2022","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.rmed.2026.108633_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2500\/aap.2015.36.3812","article-title":"Burden of chronic obstructive pulmonary disease: healthcare costs and beyond","volume":"36","author":"May","year":"2015","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.rmed.2026.108633_bib5","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s12325-024-02855-4","article-title":"Implications of cardiopulmonary risk for the management of COPD: a narrative review","volume":"41","author":"Singh","year":"2024","journal-title":"Adv. Ther."},{"key":"10.1016\/j.rmed.2026.108633_bib6","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1007\/s12325-022-02231-0","article-title":"Fluticasone Furoate\/Umeclidinium\/vilanterol (FF\/UMEC\/VI) triple therapy compared with other therapies for the treatment of COPD: a network meta-analysis","volume":"39","author":"Ismaila","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.rmed.2026.108633_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s41030-025-00306-1","article-title":"Clinically important improvements and disease stability with fluticasone furoate\/umeclidinium\/vilanterol once-daily single-inhaler triple therapy in the ELLITHE trial: a post hoc responder analysis","author":"Beeh","year":"2025","journal-title":"Pulmonary Therapy"},{"key":"10.1016\/j.rmed.2026.108633_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.rmed.2026.108633_bib10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1164\/rccm.202108-1819PP","article-title":"An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations: the rome proposal","volume":"204","author":"Celli","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.108633_bib11","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1164\/rccm.201309-1634ST","article-title":"An official American thoracic society\/european respiratory society statement: key concepts and advances in pulmonary rehabilitation","volume":"188","author":"Spruit","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.108633_bib12","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-daily single-inhaler triple versus dual therapy in patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2026.108633_bib13","first-page":"1","article-title":"Real-world effectiveness of single-inhaler fluticasone furoate\/umeclidinium bromide\/vilanterol in Chinese patients with symptomatic chronic obstructive pulmonary disease (COPD): a post-marketing, prospective, multicenter, observational study","author":"Ma","year":"2025","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.rmed.2026.108633_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1183\/09059180.00002610","article-title":"Impact of exacerbations on COPD","volume":"19","author":"Anzueto","year":"2010","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2026.108633_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/COPD.S427770","article-title":"Real-world effectiveness of fluticasone Furoate\/umeclidinium\/vilanterol once-daily single-inhaler triple therapy for symptomatic COPD: the ELLITHE non-interventional trial","volume":"19","author":"Beeh","year":"2024","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2026.108633_bib16","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1164\/rccm.202209-1795CI","article-title":"Differential diagnosis of suspected chronic obstructive pulmonary disease exacerbations in the acute care setting: best practice","volume":"207","author":"Celli","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.108633_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0179-2023","article-title":"Prevalence and prognostic importance of exercise limitation and physical inactivity in COPD","volume":"20","author":"Vaes","year":"2024","journal-title":"Breathe"},{"key":"10.1016\/j.rmed.2026.108633_bib18","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1164\/rccm.201508-1653OC","article-title":"Insights from the COPD biomarker qualification consortium","volume":"194","author":"Celli","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.108633_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1550716","article-title":"Endothelial dysfunction in chronic obstructive pulmonary disease: an update on mechanisms, assessment tools and treatment strategies","volume":"12","author":"Marcuccio","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.rmed.2026.108633_bib20","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.2147\/COPD.S531435","article-title":"Predictors of clinical stability and mortality in COPD: a longitudinal study","volume":"20","author":"Loo","year":"2025","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126000016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126000016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:28:40Z","timestamp":1777595320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126000016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":19,"alternative-id":["S0954611126000016"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108633","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical stability under FF\/UMEC\/VI triple inhaled therapy: A 12-month real life retrospective observational study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108633"}}